Decreased serum osteocalcin levels in patients with liver cirrhosis.
Serum levels of osteocalcin (OC) have been found to be a specific biochemical parameter of bone formation. We measured serum levels of osteocalcin, parathyroid hormone (PTH) and 25-hydroxyvitamin D (25(OH)D) in 49 patients with liver cirrhosis, who are known to have an increased prevalence of metabolic bone disease, and a matched control group (n = 35). Serum levels of OC were significantly decreased in the patients with liver cirrhosis when compared to control subjects (P less than 0.001). Serum levels of 25(OH)D were decreased (P less than 0.001), whereas no statistical difference was found between the serum levels of PTH in the patients with liver cirrhosis and those of the controls. In a subgroup of 23 patients with cirrhosis of the liver and 34 control subjects, the bone mineral content (BMC) of the non-dominant forearm was determined by single photon absorptiometry. BMC was significantly lower in the patient with liver cirrhosis than the control subjects (P less than 0.04). Our data demonstrate vitamin D deficiency, decreased bone formation and a decreased BMC in patients with liver cirrhosis.
Pietschmann
P
P
Department of Internal Medicine II, University of Vienna, Austria.
Resch
H
H
Müller
C
C
Woloszczuk
W
W
Willvonseder
R
R
D015519:Bone Density; D002112:Calcifediol / Q000097:blood / Q000172:deficiency; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications; D008297:Male; D015675:Osteocalcin / Q000097:blood* / Q000172:deficiency; D010281:Parathyroid Hormone / Q000097:blood; D014808:Vitamin D Deficiency / Q000150:complications
D010281:Parathyroid Hormone; D015675:Osteocalcin; D002112:Calcifediol; D002118:Calcium